top of page

Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis

Hippocampal Functional Dynamics Are Clinically Implicated in Autoimmune Encephalitis With Faciobrachial Dystonic Seizures

Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies

Distinct HLA associations of LGI1 and CASPR2-antibody diseases

Non-inheritable predisposition to LGI1 and Caspr2 antibody diseases

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis

Neuroimmunology 2017: making progress over 20 years

Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability

Psychiatric symptoms delay the diagnosis of anti-LGI1 encephalitis

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia

The importance of early immunotherapy in patients with faciobrachial dystonic seizures

The importance of early immunotherapy in patients with faciobrachial dystonic seizures (LGI1 Limbic encephalitis)

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes

A Genetic Disposition for Autoimmune Encephalitis: Searching for Human Leukocyte Antigen (HLA) Complex Subtype

IVIG treatment for repeated hypothermic attacks associated with LGI1 antibody encephalitis

AE with LGI1 or CASPR2 (formerly called voltage-gated potassium channel-complex antibodies)

Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis

Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis

The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis

Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis

Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4

From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time

VGKC-Complex Antibodies in the Absence of LGI1 and Caspr2 Antibodies

Unexplicated neuropsychiatric disorders a case report LGI1

Creutzfeldt-Jakob Disease-Like Periodic Sharp Wave Complexes in VGKC Antibodies Encephalitis: A Case Report

Clinical spectrum and diagnostic value of antibodies against the potassium channel-related protein complex


Our website is not a substitute for independent professional medical advice. Nothing contained on our website is intended to be used as medical advice. No content is intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional's advice. Although THE INTERNATIONAL AUTOIMMUNE ENCEPHALITIS SOCIETY  provides a great deal of information about AUTOIMMUNE ENCEPHALITIS, all content is provided for informational purposes only. The International Autoimmune Encephalitis Society  cannot provide medical advice.

IAE Society is a Delaware Charitable Nonprofit and a registered 501(c)(3) organization.

© 2019 International Autoimmune Encephalitis Society- All Rights Reserved.

  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon
bottom of page